IQVIA Holdings Inc. (IQV)
NYSE
Real-time Data
01:30 PM
Day's Range
254.9352 wk Range
154.50Overview - IQV - IQVIA Holdings Inc.
Key Statistics
Valuation
Enterprise Value
57.07B
P/E (Trailing)
‪129.91‬
P/E (Forward)
‪17.99‬
PEG Ratio
‪-201.36‬
Price / Sales (TTM)
‪2.51‬
Price / Book
‪6.93‬
EV / EBITDA
‪18.72‬
Profitability
Gross Margin
‪32.85%‬
Profit Margin
‪8.09%‬
Operating Margin
‪13.02%‬
Return on Assets
‪5.06%‬
Return on Equity
‪22.81%‬
Ownership
Shares Outstanding
164.60M
Float
156.24M
Short % of Shares Outstanding
‪3.22%‬
Held by Insiders
‪1.08%‬
Held by Institutions
‪103.39%‬
Price stats
Beta
‪1.17‬
50-Day Avg
‪212.96‬
200-Day Avg
‪199.52‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
21 analysts
Average price target
‪$ 275.17‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - IQV - IQVIA Holdings Inc.
Peers - IQV - IQVIA Holdings Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NYSE.
Profile Summary - IQV - IQVIA Holdings Inc.
About
IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. The company supports pharmaceutical, biotechnology, medical device, and healthcare organizations in developing, testing, and commercializing therapies using extensive…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
